-

Viz.ai Names Michael Herring as Chief Financial Officer

Seasoned financial leader brings experience at leading companies in healthcare and software as a service (SaaS) to help company scale and drive durable growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named financial leader Michael Herring as chief financial officer (CFO). Mr. Herring will report to CEO Chris Mansi, leading financial strategies and overseeing the global financial organization, including planning, treasury, tax, reporting and investor relations.

“Michael’s deep experience in guiding both public and private companies will be invaluable as Viz.ai continues to scale,” said Chris Mansi, MD, CEO and co-founder at Viz.ai. “He brings a proven track record of driving strong and sustainable financial growth and deepens our leadership bench to accelerate our impact on more patients.”

Mr. Herring is a seasoned financial executive with more than 30 years of experience. He most recently served as CFO at Color Health, a health technology company, where he led the financial infrastructure and operations teams to support the company’s growth and deliver critical medical care to millions during the COVID-19 pandemic. Previously, he served as business finance officer (BFO) at Google for the Android, Play and Chrome product lines, president and CFO at Pandora Media, global operations lead at Adobe, and CFO at Omniture and Ancestry.com where he helped establish business models that scaled to over $1B in revenue.

“Now, more than ever, we need AI-powered care that increases access to life-saving treatments across our hospitals and healthcare systems,” said Mr. Herring. “I look forward to playing a meaningful role in the next chapter of Viz.ai’s growth and delivering on our mission to make healthcare work faster and smarter.”

Herring earned a bachelor’s degree in Economics from the University of California at Los Angeles and is a Certified Public Accountant.

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,500+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai OneTM is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Viz.ai


Release Versions

Contacts

Social Media Profiles
More News From Viz.ai

Viz.ai Achieves ISO/IEC 42001 Certification, Setting the Standard for Agentic AI in Healthcare

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has successfully achieved ISO/IEC 42001 certification, the international standard for Artificial Intelligence Management Systems (AIMS), following an independent audit conducted by an accredited certification body. As one of the first companies globally to achieve this accredited ISO/IEC 42001 certification, this milestone marks a significant step in form...

Viz.ai and National Rural Health Association Launch Initiative to Bring AI-Powered Detection and Care Coordination to Rural Hospitals

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with the National Rural Health Association (NRHA). Through the organization's Rural Hospital & Clinic Partnership Program, the initiative aims to help rural hospital leaders better understand and implement AI tools that enable earlier detection of life-threatening conditions and faster care coordination. Research shows that rural hospitals are...

Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic commercialization collaboration with Johnson & Johnson to expand access to Viz.ai’s Subdural Hemorrhage software solution across hospitals in the United States for automated detection, labeling and quantification of subdural collections. By integrating the Viz Subdural solution into its neurovascular offerings, the company aims to support hospital...
Back to Newsroom